BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25989659)

  • 1. [Reduced expression of Diceri is associated with poor prognosis in patients with nasopharyngeal carcinoma].
    Xu S; Jiang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):126-31. PubMed ID: 25989659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; He QM; Huang BJ; Sun Y; Xie D; Zeng J; Wang HY; Ma J
    Med Oncol; 2013 Mar; 30(1):360. PubMed ID: 23307239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
    BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.
    Guo X; Liao Q; Chen P; Li X; Xiong W; Ma J; Li X; Luo Z; Tang H; Deng M; Zheng Y; Wang R; Zhang W; Li G
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):49-56. PubMed ID: 21953080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinase 14 Overexpression Is Correlated with the Progression and Poor Prognosis of Nasopharyngeal Carcinoma.
    Yan TH; Lin ZH; Jiang JH; Lu SW; Que HX; Chen MA; He XS; Que GB; Xiao JN; Chen YQ
    Arch Med Res; 2015 Apr; 46(3):186-92. PubMed ID: 25829357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma.
    Li WF; Liu N; Cui RX; He QM; Chen M; Jiang N; Sun Y; Zeng J; Liu LZ; Ma J
    J Transl Med; 2012 Apr; 10():78. PubMed ID: 22537306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma.
    Xu Y; Zheng Z; Gao Y; Duan S; Chen C; Rong J; Wang K; Yun M; Weng H; Ye S; Zhang J
    Sci Rep; 2017 Apr; 7(1):745. PubMed ID: 28389646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.
    Xu L; Fan S; Zhao J; Zhou P; Chu S; Luo J; Wen Q; Chen L; Wen S; Wang L; Shi L
    Diagn Pathol; 2017 Jan; 12(1):2. PubMed ID: 28061788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.
    Kontos CK; Fendri A; Khabir A; Mokdad-Gargouri R; Scorilas A
    BMC Cancer; 2013 Jun; 13():293. PubMed ID: 23777485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
    Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
    Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
    Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
    Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
    Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
    Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
    Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.
    Li Y; Yan X; Yan L; Shan Z; Liu S; Chen X; Zou J; Zhang W; Jin Z
    Int J Clin Exp Pathol; 2015; 8(4):3919-27. PubMed ID: 26097576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
    Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
    Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression level of NUAK1 in human nasopharyngeal carcinoma and its prognostic significance.
    Liu J; Tang G; Huang H; Li H; Zhang P; Xu L
    Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2563-2573. PubMed ID: 30121842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
    Wang S; Fang W
    Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
    Liu Z; Wu K; Yang Z; Wu A
    Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma.
    Jiang Q; Mai C; Yang H; Wu Q; Hua S; Yan C; Long Y; Zhang Y; Long X; Fang W; Liu Z
    Histopathology; 2014 Apr; 64(5):722-30. PubMed ID: 24168228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.
    Xu Y; Zhou L; Zong J; Ye Y; Chen G; Chen Y; Liao X; Guo Q; Qiu S; Lin S; Chen H; Pan J
    Oncotarget; 2017 Jun; 8(26):42007-42019. PubMed ID: 28159927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.